SARS-CoV-2 infection in children with rheumatic disease: Experience of a tertiary referral center.
Betül SözeriFerhat DemirSevinç KalinCanan Hasbal AkkusEnes SalıDeniz ÇakırPublished in: Archives of rheumatology (2021)
Children with rheumatic disease do not appear to present a higher risk of severe COVID-19. The immunosuppressive treatments can be adjusted in case of infection; otherwise, it is not recommended to interrupt the treatments. Physicians should be cautious about the hyperinflammatory syndrome associated with COVID-19 in rheumatic children, which may be severe in this group of patients and may be confused with primary diseases.